Skip to main content
Charles Rogers, MD, Radiation Oncology, Salt Lake City, UT, Barrow Neurological Institute

CharlesLelandRogersMDFACR, FASTRO

Radiation Oncology Salt Lake City, UT

Central Nervous System Cancer

Physician

Dr. Rogers is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Rogers' full profile

Already have an account?

Summary

  • Dr. Charles Rogers is a radiation oncologist in Phoenix, AZ. He received his medical degree from University of Kentucky College of Medicine and has been in practice 31 years. He specializes in central nervous system cancer, treatment of benign disease with radiotherapy, and brachytherapy.

Education & Training

  • University of North Carolina Hospitals
    University of North Carolina HospitalsResidency, Radiation Oncology, 1988 - 1991
  • University of Arizona College of Medicine-Phoenix
    University of Arizona College of Medicine-PhoenixInternship, Internal Medicine, 1986 - 1987
  • University of Kentucky College of Medicine
    University of Kentucky College of MedicineClass of 1986

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 1992 - Present
  • UT State Medical License
    UT State Medical License 1987 - 2026
  • AZ State Medical License
    AZ State Medical License 1991 - 2025
  • VA State Medical License
    VA State Medical License 2014 - 2018
  • NC State Medical License
    NC State Medical License 1988 - 1991
  • American Board of Radiology Radiation Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Could low dose thoracic radiation be a treatment for COVID-19 patients to prevent respiratory failure?  
    Wilson GD, Mehta MP, Welsh JS, Chakravarti A, Rogers CL, Fontanesi J, Radiation Research, 2020
  • Hughes J. Evolution of postoperative pituitary resection cavities assessed by magnetic resonance imaging and implications regarding choice of radiation therapy modality.  
    Farnworth M, Yuen KCJ, Youssef, EF, Chapple K, Matthees N, Leach G, Ngo T, Rabang J, White W, Little, AS, Rogers L, Hughes J, Pituitary, 2020
  • Long-term analysis of the WHO-defined molecular subgroups of high-risk low-grade gliomas treated with radiation and temozolomide on NRG Oncology / RTOG 0424  
    Bell EH, Pugh SL, Fisher BJ, Lesser GL, Macdonald DR, Fleming JL, McElroy JOP, Becker AP, Rogers CL, Doyle TJ, Werner-Wasik M, Ribidoux A, Yu HHM, D’Souza DP, Laack NN..., ASCO, 2020
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Hospital Affiliations